A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium

BACKGROUND: Recent studies have demonstrated the effectiveness of cisplatin-based combinations in patients with advanced transitional cell carcinoma(TCC) of the urothelium. Concern over cisplatin toxicity instigated a search for alternative regimens. The aim of the study was to evaluate the activity...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Nong, Zhang, Xiao Chen, Xiong, Jian Ping, Fang, Wei Jia, Yu, Lan Fang, Qian, Jiong, Zhang, Ling
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1906828/
https://www.ncbi.nlm.nih.gov/pubmed/17559681
http://dx.doi.org/10.1186/1471-2407-7-98

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1906828/
https://www.ncbi.nlm.nih.gov/pubmed/17559681
http://dx.doi.org/10.1186/1471-2407-7-98

Ejemplares similares